Roberta Xavier

Roberta Xavier is a Clinical Quality Associate Director at AstraZeneca, bringing over 15 years of experience in clinical research, primarily in oncology. With extensive knowledge of ICH/GCP and regulations for clinical trials, Roberta has participated in more than twenty Phase 2 and Phase 3 studies, including a COVID-19 vaccine study, and has held various roles such as Clinical Quality Manager and Local Study Lead. They have a strong background in developing and managing clinical procedures, providing training, and conducting quality control activities while overseeing KPIs across 23 countries during study phases. Roberta's education includes a Bachelor’s Degree in Pharmacy and various specializations in Business Administration and Translation.